{"transactions":[{"id":1227148,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-03-04T21:59:22.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":583,"price":4.75,"value":2769.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13109,"source":{"system":"sec-edgar","filing":"0001415889-25-006576","document":"form4-03042025_090317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588925006576/form4-03042025_090317.xml","form_type":"4"}},{"id":1280123,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-02-07T00:15:34.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":372,"price":4.72,"value":1755.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $4.72 to $4.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total number of securities reported as beneficially owned following the reported transaction reflects the 1-for-12 reverse stock split that was effected by the Issuer on December 30, 2024."}],"balance_after":13692,"source":{"system":"sec-edgar","filing":"0001415889-25-003295","document":"form4-02072025_120231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588925003295/form4-02072025_120231.xml","form_type":"4"}},{"id":1374042,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-06T21:51:22.000Z","date":"2024-11-04","kind":"sale","planned":false,"acquired":false,"shares":3668,"price":0.29,"value":1063.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":168768,"source":{"system":"sec-edgar","filing":"0001415889-24-026248","document":"form4-11062024_091118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924026248/form4-11062024_091118.xml","form_type":"4"}},{"id":1442592,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-02T20:05:11.000Z","date":"2024-08-01","kind":"sale","planned":false,"acquired":false,"shares":4149,"price":0.35,"value":1452.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":172436,"source":{"system":"sec-edgar","filing":"0001415889-24-020605","document":"form4-08022024_040806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924020605/form4-08022024_040806.xml","form_type":"4"}},{"id":1526077,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-06T20:15:59.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":3936,"price":0.75,"value":2952.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":176585,"source":{"system":"sec-edgar","filing":"0001415889-24-012322","document":"form4-05062024_040544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924012322/form4-05062024_040544.xml","form_type":"4"}},{"id":1602558,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-04T21:19:05.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":5834,"price":0.89,"value":5192.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":180521,"source":{"system":"sec-edgar","filing":"0001415889-24-006273","document":"form4-03042024_090323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924006273/form4-03042024_090323.xml","form_type":"4"}},{"id":1648855,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-12T22:10:31.000Z","date":"2024-02-08","kind":"sale","planned":false,"acquired":false,"shares":35575,"price":0.53,"value":18854.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":186355,"source":{"system":"sec-edgar","filing":"0001415889-24-003395","document":"form4-02122024_100215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924003395/form4-02122024_100215.xml","form_type":"4"}},{"id":1658384,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-05T21:26:05.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":4981,"price":0.55,"value":2739.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":221930,"source":{"system":"sec-edgar","filing":"0001415889-24-002513","document":"form4-02052024_090257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924002513/form4-02052024_090257.xml","form_type":"4"}},{"id":1658383,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-05T21:26:05.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that vested under a performance-based restricted stock unit award (the \"Award\") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals."}],"balance_after":226911,"source":{"system":"sec-edgar","filing":"0001415889-24-002513","document":"form4-02052024_090257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924002513/form4-02052024_090257.xml","form_type":"4"}},{"id":1749469,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-03T20:37:53.000Z","date":"2023-11-02","kind":"sale","planned":false,"acquired":false,"shares":3796,"price":1.22,"value":4631.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":164411,"source":{"system":"sec-edgar","filing":"0001209191-23-054332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123054332/doc4.xml","form_type":"4"}},{"id":1814745,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-04T21:21:53.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":4307,"price":3.07,"value":13222.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":168207,"source":{"system":"sec-edgar","filing":"0001209191-23-044636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123044636/doc4.xml","form_type":"4"}},{"id":1899279,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-09T20:22:31.000Z","date":"2023-05-05","kind":"sale","planned":true,"acquired":false,"shares":3869,"price":4.4,"value":17023.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":172514,"source":{"system":"sec-edgar","filing":"0001209191-23-028247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123028247/doc4.xml","form_type":"4"}},{"id":1965262,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-07T21:47:40.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":5987,"price":9.71,"value":58133.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":176383,"source":{"system":"sec-edgar","filing":"0001209191-23-016796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123016796/doc4.xml","form_type":"4"}},{"id":1972288,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:35:23.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":250000,"derivative":{"exercise_price":10.06,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-015553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123015553/doc4.xml","form_type":"4"}},{"id":2032421,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T23:38:59.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":4191,"price":11.8,"value":49453.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021 and does not represent a discretionary trade by the Reporting Person."}],"balance_after":182370,"source":{"system":"sec-edgar","filing":"0001209191-23-007170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123007170/doc4.xml","form_type":"4"}},{"id":2110083,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-18T22:23:30.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":14470,"price":11.13,"value":161051.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021, and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.13 to $11.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":186561,"source":{"system":"sec-edgar","filing":"0001209191-22-057948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122057948/doc4.xml","form_type":"4"}},{"id":2303806,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-05T21:48:17.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":2006,"price":12.67,"value":25416.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on May 28, 2021 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021, and does not represent a discretionary trade by the Reporting Person."}],"balance_after":201031,"source":{"system":"sec-edgar","filing":"0001209191-22-023237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122023237/doc4.xml","form_type":"4"}},{"id":2364636,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T21:17:15.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":121000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":121000,"derivative":{"exercise_price":10.46,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":121000},"source":{"system":"sec-edgar","filing":"0001209191-22-013988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122013988/doc4.xml","form_type":"4"}},{"id":2364635,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-01T21:17:15.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in three equal annual installments on each of February 25, 2023, February 25, 2024 and February 25, 2025, in each case, subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date."}],"balance_after":203037,"source":{"system":"sec-edgar","filing":"0001209191-22-013988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122013988/doc4.xml","form_type":"4"}},{"id":2525845,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Senior Advisor"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-03T12:15:20.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":566000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares will vest and become exercisable on October 29, 2022 and the remainder will vest over the following 12 equal quarterly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date. These options were granted to the Reporting Person pursuant to the Employment Agreement."}],"balance_after":566000,"derivative":{"exercise_price":16.83,"expiration_date":"2031-10-29","underlying":"Common Stock","underlying_shares":566000},"source":{"system":"sec-edgar","filing":"0001209191-21-062593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121062593/doc4.xml","form_type":"4"}},{"id":2525844,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Senior Advisor"}}],"security":"Common Stock","published_at":"2021-11-03T12:15:20.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":142000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares underlying RSUs granted to the Reporting Person pursuant to the Employment Agreement. Each RSU represents the contingent right to receive one share of common stock of the Issuer. 25% of the RSUs will vest on October 29, 2022 and the remainder will vest over the following 12 equal quarterly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date."}],"balance_after":164037,"source":{"system":"sec-edgar","filing":"0001209191-21-062593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121062593/doc4.xml","form_type":"4"}},{"id":2525843,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Senior Advisor"}}],"security":"Common Stock","published_at":"2021-11-03T12:15:20.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":5941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to an Employment Agreement, dated October 29, 2021, between the Reporting Person and the Issuer, whereby the Reporting Person is employed as a Senior Advisor to the Issuer effective October 29, 2021 and as President and Chief Executive Officer of the Issuer effective November 9, 2021 (the \"Employment Agreement\"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest in full on March 31, 2022, subject to the Reporting Person's continued service to the Issuer on such date."}],"balance_after":22037,"source":{"system":"sec-edgar","filing":"0001209191-21-062593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121062593/doc4.xml","form_type":"4"}},{"id":2678952,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-07T23:33:07.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":10800,"derivative":{"exercise_price":13.06,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001209191-21-038764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038764/doc4.xml","form_type":"4"}},{"id":2678951,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T23:33:07.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":2304,"price":13.04,"value":30044.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on June 3, 2021. The sales were effected pursuant to a \"sell-to-cover\" arrangement adopted in accordance with Rule 10b5-1 on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":16096,"source":{"system":"sec-edgar","filing":"0001209191-21-038764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038764/doc4.xml","form_type":"4"}},{"id":2678950,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T23:33:07.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":18400,"source":{"system":"sec-edgar","filing":"0001209191-21-038764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038764/doc4.xml","form_type":"4"}},{"id":2969620,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T01:28:30.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":2000,"price":15.819,"value":31638.0,"ownership":{"direct":true},"balance_after":11200,"source":{"system":"sec-edgar","filing":"0001209191-20-060097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120060097/doc4.xml","form_type":"4"}},{"id":3118291,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T21:46:31.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2021 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":10800,"derivative":{"exercise_price":15.62,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001209191-20-035060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120035060/doc4.xml","form_type":"4"}},{"id":3118290,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T21:46:31.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 4, 2021 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":13200,"source":{"system":"sec-edgar","filing":"0001209191-20-035060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120035060/doc4.xml","form_type":"4"}},{"id":3498533,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T22:03:04.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2020 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":20.44,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-19-035225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119035225/doc4.xml","form_type":"4"}},{"id":3498532,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T22:03:04.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 4, 2020 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-035225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119035225/doc4.xml","form_type":"4"}},{"id":3851705,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":82427,"kind":"person","name":"Posner Christopher","position":1,"cik":"0001748265","reported_name":"Posner Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-06T21:54:34.000Z","date":"2018-08-02","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable in three equal annual installments beginning on August 2, 2019, subject to the reporting person's continued service as a director through each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.94,"expiration_date":"2028-08-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-18-045588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919118045588/doc4.xml","form_type":"4"}}]}